Continental Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-16,263
Closed -$2.74M 83
2019
Q3
$2.74M Sell
16,263
-4,000
-20% -$652K 1.62% 23
2019
Q2
$3.39M Buy
20,263
+4,000
+25% +$554K 1.92% 15
2019
Q1
$2.38M Sell
16,263
-7,437
-31% -$1.08M 1.11% 35
2018
Q4
$3.17M Hold
23,700
0.97% 43
2018
Q3
$4.51M Sell
23,700
-2,700
-10% -$496K 0.99% 36
2018
Q2
$4.4M Buy
26,400
+700
+3% +$112K 1.1% 36
2018
Q1
$4.33M Buy
25,700
+7,800
+44% +$1.31M 1.1% 34
2017
Q4
$2.93M Buy
17,900
+12,700
+244% +$2.28M 0.63% 57
2017
Q3
$1.07M Sell
5,200
-500
-9% -$116K 0.24% 86
2017
Q2
$1.39M Sell
5,700
-2,800
-33% -$658K 0.31% 88
2017
Q1
$2.03M Sell
8,500
-2,200
-21% -$512K 0.45% 66
2016
Q4
$2.25M Buy
10,700
+2,600
+32% +$539K 0.61% 54
2016
Q3
$1.87M Buy
8,100
+4,400
+119% +$1.08M 0.52% 63
2016
Q2
$855K Buy
3,700
+3,100
+517% +$715K 0.26% 91
2016
Q1
$161K Buy
+600
New +$172K 0.05% 128

Other funds holding AGN

Continental Advisors's AGN Position: Q4 2019 in Review

Continental Advisors sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 16,263 shares — an estimated $2.74M sold.

Continental Advisors first reported a position in AGN in Q1 2016 and held it in 15 quarters. The position peaked at $4.51M in Q3 2018. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Continental Advisors reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Continental Advisors sold 16,263 Allergan plc shares in Q4 2019, an estimated $2.74M.
  • Continental Advisors first reported a position in Allergan plc in Q1 2016 and held it in 15 quarters.
  • Continental Advisors's Allergan plc position peaked at $4.51M in Q3 2018.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Continental Advisors's 13F filing for Q4 2019, filed 10 Feb 2020.